These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Clear cell carcinomas of the ovary: a multi-institutional study of 129 cases in Korea with prognostic significance of Emi1 and Galectin-3. Min KW, Park MH, Hong SR, Lee H, Kwon SY, Hong SH, Joo HJ, Park IA, An HJ, Suh KS, Oh HK, Yoo CW, Kim MJ, Chang HK, Jun SY, Yoon HK, Chang ED, Kim DW, Kim I, Gynecologic Pathology Study Group of the Korean Society of Pathologists. Int J Gynecol Pathol; 2013 Jan; 32(1):3-14. PubMed ID: 23202783 [Abstract] [Full Text] [Related]
5. Prognostic implication of endometriosis in clear cell carcinoma of the ovary. Orezzoli JP, Russell AH, Oliva E, Del Carmen MG, Eichhorn J, Fuller AF. Gynecol Oncol; 2008 Sep; 110(3):336-44. PubMed ID: 18639330 [Abstract] [Full Text] [Related]
7. [Clinicopathologic analysis and expression of cyclin D1 and p53 of ovarian borderline tumors and carcinomas]. Shao HL, Shen DH, Xue WC, Li Y, Yu YZ. Zhonghua Fu Chan Ke Za Zhi; 2007 Apr; 42(4):227-32. PubMed ID: 17631760 [Abstract] [Full Text] [Related]
12. When 'never-events' occur despite adherence to clinical guidelines: the case of venous thromboembolism in clear cell cancer of the ovary compared with other epithelial histologic subtypes. Duska LR, Garrett L, Henretta M, Ferriss JS, Lee L, Horowitz N. Gynecol Oncol; 2010 Mar; 116(3):374-7. PubMed ID: 19922988 [Abstract] [Full Text] [Related]
18. Endometriosis-associated ovarian carcinoma (EAOC): an entity distinct from other ovarian carcinomas as suggested by a nested case-control study. Erzen M, Rakar S, Klancnik B, Syrjänen K. Gynecol Oncol; 2001 Oct; 83(1):100-8. PubMed ID: 11585420 [Abstract] [Full Text] [Related]